PHILADELPHIA — (Aug. 17, 2021) — The Wistar Institute announces that the National Institutes of Health (NIH) granted a five-year, $29.15 million Martin Delaney Collaboratories for HIV Cure Research award to the BEAT-HIV Martin Delaney Collaboratory…
On August 12, Wistar hosted a ceremony for the Biomedical Technician Training (BTT) Program graduates of 2020 and 2021 and the Biomedical Research Technician (BRT) Apprenticeship graduates of 2021. Dr. Dario Altieri, Wistar president and CEO, welcom…
PHILADELPHIA — (July 30, 2021) — The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, announces the appointment of Daniel Claiborne, Ph.D., as Caspar Wistar Fellow in the Vaccine & Immu…
In a recent Cell Reports paper, Dr. Bin Tian and team revealed a mechanism that has far-reaching implications in development and diseases, including immunity and cancers. The lab studies RNA biology to understand just how gene expression is regulate…
PHILADELPHIA — (July 20, 2021) — Alternative polyadenylation (APA) is an RNA processing mechanism that regulates gene expression by generating different ends on RNA transcripts of the same gene. Though it affects more than half of human genes, the s…
Dedicated to the memory of melanoma research champions Dr. Shyam Somasundaram, Wistar scientist, and Eleanor Murdoch, melanoma advocate and mother of Noreen and Kate O’Neill, this year’s Symposium brought together international experts in basic and…
Antiretroviral therapy (ART) is highly effective at controlling HIV infection, keeping the amount of virus in the blood so low as to be undetectable. This condition is called viral suppression. Yet most people experience viral rebound and disease pr…
After a day of virtual scientific talks that concluded Wistar’s 4th annual Noreen O’Neill Melanoma Research Symposium, a lay-friendly examination of melanoma with a group of interdisciplinary scientists continued into the evening during the Women &a…
PHILADELPHIA — (June 29, 2021) — New biomarkers that predict HIV remission after antiretroviral therapy (ART) interruption are critical for the development of new therapeutic strategies that can achieve infection control without ART, a condition def…
PHILADELPHIA — (June 2, 2021) — The Wistar Institute, an international biomedical research leader with special expertise in cancer, immunology and infectious disease research and vaccine development, will require all employees to be vaccinated again…
